Eterna Therapeutics
ERNA
#11091
Rank
โ‚น0.37 B
Marketcap
โ‚น232.15
Share price
-3.61%
Change (1 day)
95.25%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -โ‚น2,608

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น2,833. In 2022 the company made an earnings per share (EPS) of -โ‚น3,04,337 an increase over its 2021 EPS that were of -โ‚น20,10,654.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,608
2022-โ‚น3,04,337-84.86%
2021-โ‚น20,10,654

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น184.07-106.50%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น200.23-92.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚น165.41-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.64-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น60.94-102.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น113.17-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA